My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 151

    1.

    Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.

    Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, Ciani S, Messeri G, Rotella CM.

    Diabetes Care. 2001 Mar;24(3):489-94.PMID: 11289473 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.

    Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, Ciani S, Fanelli A, Messeri G, Rotella CM.

    Diabet Med. 2000 Oct;17(10):713-9.PMID: 11110504 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes.

    Mannucci E, Tesi F, Bardini G, Ognibene A, Petracca MG, Ciani S, Pezzatini A, Brogi M, Dicembrini I, Cremasco F, Messeri G, Rotella CM.

    Diabetes Nutr Metab. 2004 Dec;17(6):336-42.PMID: 15887627 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.

    Ryan AS, Egan JM, Habener JF, Elahi D.

    J Clin Endocrinol Metab. 1998 Jul;83(7):2399-404.PMID: 9661618 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.

    Nauck MA, Weber I, Bach I, Richter S, Orskov C, Holst JJ, Schmiegel W.

    Diabet Med. 1998 Nov;15(11):937-45.PMID: 9827848 [PubMed - indexed for MEDLINE]Related articles

    6.

    Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.

    Zander M, Taskiran M, Toft-Nielsen MB, Madsbad S, Holst JJ.

    Diabetes Care. 2001 Apr;24(4):720-5.PMID: 11315837 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.

    Lugari R, Dei Cas A, Ugolotti D, Barilli AL, Camellini C, Ganzerla GC, Luciani A, Salerni B, Mittenperger F, Nodari S, Gnudi A, Zandomeneghi R.

    Horm Metab Res. 2004 Feb;36(2):111-5.PMID: 15002062 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals.

    Mersebach H, Svendsen OL, Holst JJ, Astrup A, Feldt-Rasmussen U.

    Clin Endocrinol (Oxf). 2003 Jan;58(1):65-71.PMID: 12519414 [PubMed - indexed for MEDLINE]Related articles

    9.

    Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.

    Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, Gallwitz B.

    Diabetes. 2004 Mar;53(3):654-62.PMID: 14988249 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.

    Balkan B, Kwasnik L, Miserendino R, Holst JJ, Li X.

    Diabetologia. 1999 Nov;42(11):1324-31.PMID: 10550416 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.

    Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Ehlers MR, Egan JM, Elahi D.

    Diabetes Care. 2003 Mar;26(3):837-42.PMID: 12610046 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity.

    Green BD, Mooney MH, Gault VA, Irwin N, Bailey CJ, Harriott P, Greer B, O'Harte FP, Flatt PR.

    J Endocrinol. 2004 Mar;180(3):379-88.PMID: 15012592 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.

    Elahi D, Egan JM, Shannon RP, Meneilly GS, Khatri A, Habener JF, Andersen DK.

    Obesity (Silver Spring). 2008 Jul;16(7):1501-9. Epub 2008 Apr 17.PMID: 18421270 [PubMed - indexed for MEDLINE]Related articles

    14.

    Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

    Egan JM, Meneilly GS, Habener JF, Elahi D.

    J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73.PMID: 12161508 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion.

    Deacon CF, Plamboeck A, Møller S, Holst JJ.

    Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E873-9.PMID: 11882507 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.

    Ranganath L, Norris F, Morgan L, Wright J, Marks V.

    Clin Sci (Lond). 1999 Apr;96(4):335-42.PMID: 10087239 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.

    Green BD, Irwin N, Duffy NA, Gault VA, O'harte FP, Flatt PR.

    Eur J Pharmacol. 2006 Oct 10;547(1-3):192-9. Epub 2006 Jul 27.PMID: 16945366 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males.

    Jeibmann A, Zahedi S, Simoni M, Nieschlag E, Byrne MM.

    Eur J Clin Invest. 2005 Sep;35(9):565-72.PMID: 16128863 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.

    Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Elahi D.

    J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):M681-5.PMID: 11682575 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity